Skip to Main Content

Paper Details

Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples.
Oncotarget
32
2018
-expressing monocytes, -expressing supportive monocyte, /, /macrophages, ARRY-382, B, B-cell receptor, CD14, CD14-expressing monocytes, CLL, CLL cells, CLL samples, CSF1R, GW-2580, NLCs, chronic lymphocytic leukemia, colony-stimulating factor 1 receptor, ibrutinib, idelalisib, leukemia, leukemia cells, macrophages, malignancies, monocyte, monocyte cell, nurse-like cells, patient, primary CLL, tumor, tumor cell, white cell
Author NameAffiliation
David K EdwardsOregon Health & Science University
David Tyler SweeneyOregon Health & Science University Knight Cancer Institute
Hibery HoOregon Health & Science University Knight Cancer Institute
Christopher A EideOregon Health & Science University Knight Cancer Institute
Angela RofeltyOregon Health & Science University Knight Cancer Institute
Anupriya AgarwalOregon Health & Science University Knight Cancer Institute
Selina Qiuying LiuOregon Health & Science University Knight Cancer Institute
Alexey V DanilovOregon Health & Science University Knight Cancer Institute
Patrice Lee
David Chantry
Shannon K McWeeneyOregon Health & Science University
Brian J DrukerOregon Health & Science University Knight Cancer Institute
Brian J DrukerHoward Hughes Medical Institute, Oregon Health & Science University, Knight Cancer Institute
Jeffrey W TynerOregon Health & Science University
Stephen E SpurgeonOregon Health & Science University Knight Cancer Institute
Marc M LoriauxOregon Health & Science University Knight Cancer Institute
  • 1 - 16

Datasets

Release 1.2